Close

Biostar Pharma (BSPM) Announces Launch of 'Easy Breathing' Product; Will Target Rhinitis, Sinusitis

Go back to Biostar Pharma (BSPM) Announces Launch of 'Easy Breathing' Product; Will Target Rhinitis, Sinusitis

Biostar Pharma (BSPM) Enters 425k Share Securities Purchase Agreement

October 12, 2016 9:18 AM EDT

Biostar Pharmaceuticals, Inc. (Nasdaq: BSPM) announced that it entered into a securities purchase agreement (the "Securities Purchase Agreement") with certain institutional investors for the sale of 425,000 shares of common stock in a registered direct offering at the price of $4.50 per share. In addition, warrants to purchase 212,500 shares... More

Biostar Pharma (BSPM) Shares Double

October 11, 2016 1:18 PM EDT

Biostar Pharma (NASDAQ: BSPM) surged 100% intraday after earlier announcing that it will launch its new topical health product called in the PRC in November 2016.

... More